Found 336 articles for: "eczema"
Do the Words We Choose Matter When Prescribing Medications?
December 2023 | Volume 22 | Issue 12 | Original Article | 1216 | Copyright © December 2023
Background: Caregivers are often apprehensive about treating childhood atopic dermatitis (AD) with topical corticosteroids but may find comfort if treatments are presented in a p...
Read MoreA Case Series of Patients With Eczematous Eruptions Following IL-17 Inhibitor Treatment for Psoriasis Vulgaris
December 2023 | Volume 22 | Issue 12 | Case Reports | 1225 | Copyright © December 2023
Psoriasis vulgaris and eczema are characterized by an imbalance in the Th1 and Th2 immune response and distinct cytokine profiles, where Th1 is more prominent in psoriasis and Th2 is more promine...
Read MoreINDIVIDUAL ARTICLE: Management of Prurigo Nodularis
December 2023 | Volume 22 | Issue 12 | Supplement Individual Articles | SF365502s15 | Copyright © December 2023
Background: Prurigo nodularis (PN) is a chronic disease characterized by intense pruritus and nodular lesions associated with reduced quality of life. Until recently, no US Food ...
Read MoreINDIVIDUAL ARTICLE: Pediatric Atopic Dermatitis Patient Cases Integrating Ceramides-Containing Cleansers and Moisturizers into Prescription Treatment and Maintenance Approaches
December 2023 | Volume 22 | Issue 12 | Supplement Individual Articles | SF389716s3 | Copyright © December 2023
Introduction: Atopic dermatitis (AD) is a common, chronic recurrent disorder typically starting in infancy and early childhood and associated with pruritus and genetic predisposi...
Read MoreNot So Vanilla: What Dermatologists Should Know About Vanilloid Receptors
December 2023 | Volume 22 | Issue 12 | Features | 1237 | Copyright © December 2023
Topical Moisturizer Meaningfully Reduces Disease Severity in Atopic Patients With Xerosis
December 2023 | Volume 22 | Issue 12 | Editorials | e51 | Copyright © December 2023
Background: Repairing the epidermal barrier is critically important in atopic dermatitis (AD), but the effect of moisturizer on quality of life (QOL) is not well characterized.&n...
Read MoreINDIVIDUAL ARTICLE: USCOM Algorithm for the Prevention and Management of Cutaneous Immunotherapy-Related Adverse Events
November 2023 | Volume 22 | Issue 11 | Supplement Individual Articles | SF389716s4 | Copyright © November 2023
Background: In 2023, nearly 2 million patients will be diagnosed with cancer in the United States and at least 40% will be eligible for treatment with an immune checkpoint inhibi...
Read MoreEvaluating Quality and Reliability of Most-Viewed YouTube Videos on Topical Steroid Withdrawal
November 2023 | Volume 22 | Issue 11 | Features | 1128 | Copyright © November 2023
Epidemiology of Chronic Dermatologic Conditions in Skin of Color
November 2023 | Volume 22 | Issue 11 | Features | e21 | Copyright © November 2023
Across the board, common dermatologic conditions disproportionately affect patients of color. While the causes of these disparities have been tied to the environment, societal structure, access t...
Read MoreFULL SUPPLEMENT: The Importance of Skincare in Eczema: A Novel Over-the-Counter Routine Improves Signs and Symptoms in Patients with Eczema
October 2023 | Volume 22 | Issue 10 | Department | SF388641s1 | Copyright © October 2023
In the United States, the National Eczema Association estimates that 1 out of every 10 people have some form of eczema over their lifetime. As any dermatologist can attest, managing patients with...
Read MoreIndividual Article: Evaluation of Efficacy and Tolerability of Two Over-the-Counter Eczema Itch Relief Products
October 2023 | Volume 22 | Issue 10 | Supplement Individual Articles | SF388641s10 | Copyright © October 2023
Background: Study to compare efficacy, tolerability, and patient perception between an over-the-counter itch relief gel (IRG) and itch relief moisturizing cream (IRMC) after a si...
Read MoreIndividual Article: A Novel 3-Step Over-the-Counter Eczema Regimen Improves Eczema Severity, Itch, and Life Quality: Randomized Study
October 2023 | Volume 22 | Issue 10 | Supplement Individual Articles | SF388641s21 | Copyright © October 2023
Background: Eczema, or atopic dermatitis (AD), is a chronic relapsing skin disease associated with unpredictable flares of erythema, rash, and pruritus. AD arises from a combinat...
Read MoreIndividual Article: Over-the-Counter Moisturizers Significantly Improve Skin Hydration in Adults With Eczema/Atopy-Prone Skin
October 2023 | Volume 22 | Issue 10 | Supplement Individual Articles | SF388641s16 | Copyright © October 2023
Background: Many adults suffer from dry, itchy skin, particularly those with eczema-prone skin. This study evaluated the effects of two over-the-counter (OTC) moisturizing produc...
Read MoreIndividual Article: Efficacy of Over-The-Counter Cream in Reducing Eczema Signs
October 2023 | Volume 22 | Issue 10 | Supplement Individual Articles | SF388641s5 | Copyright © October 2023
Background: Eczema (also called atopic dermatitis) is a chronic, relapsing skin disease characterized by erythema, scaling, and pruritus.
Methods: Study 1....
Read MoreA Review of the Current Landscape of Hidradenitis Suppurativa Treatment Development
October 2023 | Volume 22 | Issue 10 | Original Article | 1021 | Copyright © October 2023
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by recurrent nodules and abscesses leading to subsequent scarring and tunnel form...
Read MoreParticipant Satisfaction of a Community-based Telehealth Clinic for Atopic Dermatitis
October 2023 | Volume 22 | Issue 10 | Editorials | 1066 | Copyright © October 2023
Atopic dermatitis (AD), a chronic, relapsing inflammatory disease that affects more than 30 million children and adults in the US, disproportionally impacts African American (AA) and Hispanic children...
Read MoreUnexpected Clinical Lessons Learned From IL-4 and IL-13 Blockade
October 2023 | Volume 22 | Issue 10 | Editorials | 1007 | Copyright © October 2023
In 2017, dupilumab became the first FDA approved systemic therapy for atopic dermatitis. Since its approval, extensive clinical experience and continued research have revealed a number of unexpected e...
Read MoreAnt Venom-Based Ceramide Therapy Is Effective Against Atopic Dermatitis In Vivo
October 2023 | Volume 22 | Issue 10 | Original Article | 1001 | Copyright © October 2023
Background: Atopic dermatitis (AD) is a common skin condition with relatively few therapeutic alternatives. These include corticosteroids, which address inflammation but not superinfe...
Read MoreOff-Label Use of Baricitinib in Dermatology
August 2023 | Volume 22 | Issue 8 | Original Article | 795 | Copyright © August 2023
The current US Food and Drug Administration (FDA) indications for baricitinib include alopecia areata, rheumatoid arthritis, and COVID-19. However, increasing evidence indicates that baricitinib ...
Read MoreINDIVIDUAL ARTICLE: An Algorithm for the Management of Atopic Dermatitis in People With Skin of Color
August 2023 | Volume 22 | Issue 8 | Supplement Individual Articles | SF386361s3 | Copyright © August 2023
Media and other results for: "eczema"